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INTRODUCTION
The gut microbiome plays a key role in a wide
range of host-related processes and has a profound
effect on human health. Comparative analyses of the
human gut microbiome have revealed its substantial
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variation in species and gene composition within a
variety of disease states and even among healthy
individuals but may fall short of providing a compre-
hensive understanding of the impact of this variation
on the microbial community and on the host (1). It
has been argued that an imbalance in microbial
population in the intestinal tract is a trigger factor
for gut inflammation. Inflammatory bowel disease
arises from disruption of immune tolerance to the
gut commensal microbes, leading to chronic intes-
tinal inflammation and mucosal damage in geneti-
cally predisposed hosts (2). Many reports have
shown that the integrity of gut microbiome is im-
portant to prevent the inflammatory bowel disease
(2). In addition, the relationship between gut micro-
biome and development of colorectal cancer was
suggested in some reports (3).
Herbal medicines can affect health via the gut
microbiome in two ways. Like ginseng, a variety of
herbal medicines are known to provide pharma-
cological effect only after being processed by bac-
teria in the gut. The list includes the dried fruits of
Gardenia jasminoides , containing the compound
geniposide, which is converted by gut microbes
into its active form, genipin, another anti-inflamma-
tory and anticancer compound. Similarly, the root
of the liquorice plant, Glycyrrhiza glabra , contains
glycyrrhizin, which can be processed by gut mi-
crobes into 18β -glycyrrhetic acid, which is effective
in the treatment of peptic ulcers but also has antiviral
and antifungal activities. In other way, certain ingre-
dients of herbal medicines influence the microbial
composition in the gut. For example, extracts from
the Ginkgo leaf have been shown to increase the
abundance of symbiotic bacteria such as Lactobacil-
lus and Bifidobacterium in the gut. These microbes
have been linked with a number of health benefits
in the human host ; in particular, they can modulate
the immune system as to reduce the risk of auto-
immune diseases like type-I diabetes mellitus (2).
Dai-kenchu-to (DKT) is used for the treatment of
adhesive bowel obstruction and a feeling of coldness
in the abdomen (4-8). The pharmacological action
of DKT is gradually understood, and several studies
have shown that DKT accelerates the transit of gas-
trointestinal contents (9-13). Since the delayed tran-
sit of luminal contents could be responsible for the
bacterial overgrowth in the gut (14-17), DKT may
prohibit the harmful microbial activities. It has also
been reported that DKT increases intestinal and por-
tal blood flow (7, 18-21), resulting in the reduction
of blood ammonia level after hepatectomy (9) and
an anti-inflammation (11). We have previously re-
ported that DKT prevents the inflammatory cytokine
production in the gut and bacterial translocation in
the rat model with fast stress (4). In addition, we
have shown that DKT suppresses the inflammatory
response after surgical operation in human (6).
The aim of this study was to evaluate the effect of
DKT on the microbial diversity in inflamed gut using
the rat model with fast stress.
MATERIALS AND METHODS
Dai-kenchu-to (DKT)
A commercially available kampo medicine, DKT,
was purchased from Tumura Co. Ltd (Tokyo, Japan).
It was prepared as a dried extract powder of Ginseng
radix, Zanthoxyli fructus and Zingiberis siccaatum
rhizome in the ratio of 3 : 2 : 5 respectively. DKT
(15 g) has been used for the patients with adhe-
sive ileus. The dose of DKT for the rats was calcu-
lated to be 300 mg/kg from the amount of DKT
(15 g) administered to a patient with 50 kg body
weight.
Animals
Male Wister rats (200 to 220 g of body weight, 6-
week-old) were purchased from Charles River Inc.
(Yokohama, Japan). The experimental protocol use
in this study was reviewed and approved by the
animal committee of the Institute of Health Bi-
osciences, the University of Tokushima Graduate
School. Animals were checked to be specific-patho-
gen - free and housed under standard conditions
(Room temperature 22, humidity 505%, 12 h/
12 h light-dark cycle).
Experimental design
Four 6-week-old male were received the fast
stress for 5 days as described previously (4). The
three rats were administered daily with DKT (300
mg/kg/day) by oral gavage during the fast stress
(DKT-group), and the remaining rat was kept with-
out treatment for comparison (control group). The
alteration of gut microbiome was evaluated by PCR-
clone library method targeting the 16S ribosomal
RNA gene (16S rDNA) of the stools collected at be-
fore and after fast stress.
Analysis of gut microbiome by sequencing the 16S
rRNA gene clone libraries
To evaluate the effect of DKT on gut micorbiome
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of the fasted rats, we employed the sequencing
analysis of 16S rRNA gene (16S rDNA) clone librar-
ies method. DNAs were extracted from the rat feces
according to the method described by Morita et al.
(22), in which lysozyme and achromopeptidase
were used as lytic enzymes. Bacterial 16S rDNA
were amplified with the universal primers, 27F and
1492R (22). The amplicons were cloned into pGEM-
T Easy Vector (Promega), and the libraries were
constructed with Escherichia coli DH5α. From the
each library, 96 colonies were randomly selected
and the insert DNA fragment was amplified with
primer SP6 and T7, whose annealing sites locate
just outside the cloning site of the pGEM-T Easy
Vector. The amplicons were purified, and their nu-
cleotide sequences using the 27F as a sequencing
primer were determined by Takara Bio Inc (Otsu,
Shiga, Japan). Of the obtained sequences, low quality
sequences were removed. The uncertain nucleotides
at both ends were also trimmed. The assignment of
each 16S rDNA sequence was done by Classifier
program from the Ribosomal Database Project (22)
with confidence level of over 80%. Sequences were
aligned with Clustal W2 program and assembled
into operational taxonomic units (OTUs) with the
parameters of97% identity and90% alignment
length, and the number of OUT was used to evalu-
ate the diversity of gut microbiome. The phyloge-
netic tree was drawn by MEGA5 program.
RESULTS
< Control group >
Figure 1 and Figure 2 showed the influence of fast
stress on microbiome in the intestine, Figure 1
Figure 1 The phylogenetic tree of the microbiome component in control -group.
Figure 2 The composition of microbiome as circle figure in control -group.
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showed the tree of the microbiome component,
Figure 2 showed the composition of microbiome as
circle figure. In Control-group, Erysipelotrichaceae
increased to 86% in after-fast stress, OTU of before-
fast stress was 111 and after-fast stress was 46
(changing rate : 58%). The diversity of microbiome
was severely decreased.
< DKT group >
Figure 3 and Figure 4 showed the effect of DKT
on microbiome in the intestine after fast stress.
Figure 3 showed the tree of the microbiome com-
ponent, Figure 4 showed the composition of mi-
crobiome as circle figure. In DKT-group, diver-
sity of microbiome was kept after fast stress
(Lachnospiraceae : Ruminococcaceae : Coriobacteriales
54%, 22%, 5%). OTU of before-fast stress was 52 and
after-fast stress with DKT was 55 (changing rate :
6%). DKT maintained the diversity of microbiome
in fast stress model.
< Composition of microbiome change between the
control and DKT group >
Figure 5 showed the component of microbiome.
Compared with the microbiome of control-group,
the variation of microbiome after-fast stress with
DKT was not changed significantly. DKT main-
tained the diversity of microbiome almost normal
condition.
Figure 6 showed the OTU changing rate. The
OTU in control-group decreased to 42%, while the
OTU in DKT-group maintained at 105% compared
with before fast stress respectively.
Figure 3 The phylogenetic tree of the microbiome component in DKT-group.
Figure 4 The composition of microbiome as circle figure in DKT-group.
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DISCUSSION
The global composition of the intestinal bacte-
rial microbiome rather than the presence of single
pathogens appear to be relevant for inflammatory
bowel disease (IBD) pathogenesis and etiology.
Analysis of bacterial 16S rRNA genes, amplified di-
rectly from complex communities, provides an effi-
cient strategy to explore the bacterial diversity of
complex microbiome. Alteration of the bacterial mi-
crobiome in mucosal inflammation reflects a meta-
bolic imbalance of the complex microbial ecosystem
with severe consequences for the mucosal barrier
rather than disrupted defence to single microorgan-
isms (1, 2).
The malnutrition is associated with cometabo-
lism of microbiome and abnormal increase of mi-
crobiome is also associated with malnutrition (23).
In the inflammation and metaplasia, esophagitis
and Barrett’s esophagus (intestinal metaplasia) are
associated the microbiome change. Streptococcus
is significantly decreased and the diversity also de-
crease in esophagitis and Barrett’s esophagus (24).
Patients with inflammatory diseases and diarrhea
show a complex pattern with high inter individual
variability in microbiome. Bacterial diversity of non-
inflammatory control is significantly higher than that
of Crohn’s disease and ulcerative colitis patients,
suggesting that reduced bacterial diversity in IBD
is a disease specific feature (25). In this study, fast
Figure 5 Composition of microbiome change between the control and DKT group.
Figure 6 OTU changing rate between control and DKT group.
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stress induced the Erysipelotrichaceae sequence sig-
nificantly. And the Mollicutes belong to the Erysipe-
lotrichaceae, its increase is observed in abnormal
diet intake (26). DKT maintains the diversity of
microbiome and prevent the increase of Erysipe-
lotrichaceae sequence. The exact role of this mecha-
nism is obscure, and deserves further research.
In colon cancer (27), changing the microbiome
is related the tumorigenesis through various events
(e.g. infection, diet, stress, inflammation). Ginseng
significantly inhibited colonic inflammation and tu-
morigenesis and concomitantly reduces proliferation
and increased apoptosis through changing the di-
versity of microbiome. The epidermal growth factor
receptor (EGFR) cascade is up-regulated in colonic
tumors and ginseng significantly reduced EGFR
activation and Cox-2 expression. Dietary ginseng
altered colonic microbial diversity, and bacterial sup-
pression with metronidazole reduced serum com-
pound K following ginseng gavage. Furthermore,
compound K significantly inhibits tumor xenograft
growth. Ginseng inhibited colonic inflammation and
tumorigenesis promoted by Western diet. The gin-
seng metabolite compound K contributes to the che-
mopreventive effects of this agent in colonic tumori-
genesis. As DKT contains the ginseng which may
relate this microbial diversity, diversity change in
this study may deeply correlate to the ginseng (2).
The detail of the mechanism of the DKT for mi-
crobiome is unclear and further investigation is
needed.
Fast stress induced the loss of diversity of mi-
crobiome and the DKT keeps the diversity. Un-
changed microbiome characteristics associate with
maintaining the intestinal activity. We suggest new
mechanism of the DKT for anti-inflammatory effect
is concerned with the microbiome.
CONCLUSION
DKT maintained the diversity of microbiome
in fast stress model. Our data suggests the new
mechanism of anti-inflammatory effect of DKT.
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